Total Payments
$35,888
2024 Payments
$3,025
Companies
42
Transactions
664
Medicare Patients
18,542
Medicare Billing
$3.7M
Payment Breakdown by Category
Other$22,088 (61.5%)
Food & Beverage$11,820 (32.9%)
Consulting$1,600 (4.5%)
Travel$337.23 (0.9%)
Education$42.88 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,088 | 21 | 61.5% |
| Food and Beverage | $11,820 | 637 | 32.9% |
| Consulting Fee | $1,600 | 2 | 4.5% |
| Travel and Lodging | $337.23 | 1 | 0.9% |
| Education | $42.88 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $24,300 | 115 | $0 (2024) |
| PFIZER INC. | $3,285 | 94 | $0 (2023) |
| Medtronic, Inc. | $1,680 | 53 | $0 (2024) |
| Abbott Laboratories | $1,083 | 37 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,065 | 92 | $0 (2024) |
| SI-BONE, INC. | $584.69 | 15 | $0 (2024) |
| Amgen Inc. | $526.51 | 33 | $0 (2024) |
| Horizon Therapeutics plc | $451.48 | 34 | $0 (2022) |
| Daiichi Sankyo Inc. | $382.69 | 35 | $0 (2019) |
| Nevro Corp. | $314.29 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,025 | 49 | Boston Scientific Corporation ($1,829) |
| 2023 | $10,444 | 90 | Boston Scientific Corporation ($9,106) |
| 2022 | $7,653 | 117 | Boston Scientific Corporation ($5,954) |
| 2021 | $6,607 | 94 | BOSTON SCIENTIFIC CORPORATION ($5,065) |
| 2020 | $2,413 | 55 | Boston Scientific Corporation ($1,897) |
| 2019 | $778.83 | 67 | PFIZER INC. ($120.14) |
| 2018 | $1,203 | 91 | PFIZER INC. ($228.77) |
| 2017 | $3,764 | 101 | PFIZER INC. ($2,811) |
All Payment Transactions
664 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| 12/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/02/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $117.34 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $51.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Opioid Analgesic | ||||||
| 10/24/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $4.64 | General |
| Category: Opioid Analgesic | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $2.18 | General |
| Category: Opioid Analgesic | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $1.91 | General |
| Category: Opioid Analgesic | ||||||
| 10/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $196.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/15/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $106.65 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/05/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $120.29 | General |
| 07/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Bone Health | ||||||
| 07/18/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: General - Therapies_NMD | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 5,397 | 12,688 | $7.3M | $1.0M |
| 2022 | 36 | 5,062 | 12,665 | $6.2M | $913,923 |
| 2021 | 28 | 3,367 | 8,785 | $5.9M | $851,081 |
| 2020 | 43 | 4,716 | 10,227 | $5.3M | $892,170 |
Total Patients
18,542
Total Services
44,365
Medicare Billing
$3.7M
Procedure Codes
142
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 901 | 2,161 | $1.2M | $190,288 | 15.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 364 | 609 | $773,491 | $107,977 | 14.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 181 | 214 | $851,193 | $96,574 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 691 | 1,550 | $599,046 | $90,955 | 15.2% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 35 | 70 | $659,218 | $85,379 | 13.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 361 | 1,767 | $625,836 | $81,462 | 13.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 494 | 949 | $294,854 | $57,248 | 19.4% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 176 | 209 | $341,925 | $52,464 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 313 | 313 | $253,968 | $37,277 | 14.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 108 | 182 | $290,287 | $32,284 | 11.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 62 | 68 | $256,271 | $28,520 | 11.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 92 | 133 | $170,872 | $23,532 | 13.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 106 | 178 | $145,672 | $16,828 | 11.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 86 | 121 | $139,213 | $16,352 | 11.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 58 | 64 | $107,019 | $16,182 | 15.1% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 46 | 82 | $141,893 | $15,727 | 11.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 52 | 60 | $83,319 | $11,553 | 13.9% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 45 | 80 | $69,445 | $7,938 | 11.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 389 | 661 | $38,495 | $6,121 | 15.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 99 | 122 | $51,510 | $5,846 | 11.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $38,189 | $5,552 | 14.5% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 36 | 36 | $28,186 | $5,525 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 51 | $37,516 | $4,922 | 13.1% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 11 | 13 | $15,771 | $3,536 | 22.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 30 | 37 | $19,645 | $3,001 | 15.3% |
About Dr. John Ruxer, DO
Dr. John Ruxer, DO is a Diagnostic Radiology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1205078987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ruxer, DO has received a total of $35,888 in payments from pharmaceutical and medical device companies, with $3,025 received in 2024. These payments were reported across 664 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,088).
As a Medicare-enrolled provider, Ruxer has provided services to 18,542 Medicare beneficiaries, totaling 44,365 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Pain Medicine
- Location Paducah, KY
- Active Since 03/27/2009
- Last Updated 07/24/2025
- Taxonomy Code 2085R0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205078987
Products in Payments
- General - Therapies (Device) $5,500
- GENERAL PAIN MANAGEMENT (Device) $3,632
- EMBEDA (Drug) $2,604
- WAVEWRITER ALPHA (Device) $1,424
- INTELLIS ADAPTIVESTIM (Device) $1,201
- GENERAL - PAIN MANAGEMENT (Device) $1,045
- GENERAL - THERAPIES (Device) $969.94
- WaveWriter Alpha Prime 16 (Device) $953.25
- PROCLAIM (Device) $770.62
- Belbuca (Drug) $592.59
- XTAMPZA (Drug) $385.75
- Aimovig (Biological) $321.84
- Proclaim IPG (Device) $293.16
- Morphabond ER (Drug) $274.92
- LYRICA (Drug) $265.02
- PENNSAID (Drug) $242.83
- IFUSE IMPLANT (Device) $239.42
- NURTEC ODT (Drug) $200.17
- DUEXIS (Drug) $171.94
- SPECTRA WAVEWRITER (Device) $171.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Paducah
Keith Crawford, M.d, M.D
Diagnostic Radiology — Payments: $4,196
Diagnostic Radiology $4,196
Dr. Jennifer Brien, Md, MD
Diagnostic Radiology — Payments: $371.40
Diagnostic Radiology $371.40
Vernon Duncan, M.d, M.D
Diagnostic Radiology — Payments: $166.55
Diagnostic Radiology $166.55
Dr. Scott Mcelroy, Md, MD
Diagnostic Radiology — Payments: $138.01
Diagnostic Radiology $138.01
Dr. Joseph Lambert, M.d, M.D
Diagnostic Radiology — Payments: $109.16
Diagnostic Radiology $109.16
Russell Shields, Md, MD
Diagnostic Radiology — Payments: $103.86
Diagnostic Radiology $103.86